Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.
Trump
Administration
Supported by
Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.
By Rob Copeland and Rebecca Robbins
The Trump administration plans to ensure transparency and accuracy in drug ads, including by increasing the amount of information…
The Trump administration is preparing to impose new tariffs on drugmakers that have not struck deals with the president to lower…
Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on August 5.
The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of…
Drug companies that commit to moving production to the U.S. will face a 20% tariff and no tariff if they also agree to lower…
US president has said that he will use tariffs to bring down costly medical drugs, but the impact remains uncertain.
